The Safety and Efficacy of Embotrap in Treating Acute Ischemic Stroke Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 330 participants.

Also called NCT05667103

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 330 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05667103
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05667103. Randomized; quadruple masking; primary purpose treatment. Start 2023-01-15 (actual); primary completion 2024-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Safety and Efficacy of Embotrap in Treating Acute Ischemic Stroke Patients
Condition
Stroke
Condition
Acute Ischemic Stroke
Intervention (Device)
Embotrap stent retriever
Intervention (Device)
Solitaire FR, Trevo stent retriever without inner channel
Lead sponsor
Xuanwu Hospital, Beijing (class: other)

Record details

Record id
cardio:ct-nct05667103
Content hash
16ccec26e52d714c5b3dd1f71fb7da3061ba585d1208cff631104d71dbee5522